Med. praxi. 2011;8(3):100-103

Current new trends in allergology

MUDr.Ivana Šetinová, MUDr.Hana Maršálková, MUDr.Barbara Trnková
Imunologické centrum, Synlab czech, Praha

The prevalence of allergic people in Czech republic has reached 32 % of population. The critical role in the patogenesis of the allergic

diseases plays interaction between genes for atopy and environment. The range of risk faktors includes viral infections, pollutants, diet

and change of life style. The identification of allergens on a molecular basis, study of homology between allergens leads to the accurate

diagnosis with recombinant allergens. This is the way to find out the specific senzibilization in the individual patient. Component-resolved

diagnosis allows to find the right allergen immunotherapy and has the effect on development of new standardization vaccines.

Keywords: genes and risk environmental factors, recombinant allergens, specific senzibilization, specific allergen immunotherapy

Published: March 23, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šetinová I, Maršálková H, Trnková B. Current new trends in allergology. Med. praxi. 2011;8(3):100-103.
Download citation

References

  1. Špičák V. Měnící se tvář alergie a alergických onemocnění. Alergie 2010; 12: 83-86.
  2. Hrabina M, Peltre G, Moingeon P. Alergeny pylů trav. Alergie 2009; 11: 73-76.
  3. Moingeon P, Peltre G, Bergmann KC. Odůvodnění užívání vakciny z pylů pěti druhů trav. Alergie 2009; 11: 225-227.
  4. Ferreira F, Hawranek T, Gruber P, et al. Allergic cross-reactivity: from gene to the clinic. Allergy 2004; 59: 243-267. Go to original source... Go to PubMed...
  5. Grimshaw KEC, Allen K, Edwards A, et al. Infant feeding and allergy prevention: a review of current knowledge and recommendations. A EuroPrevall state of the art paper. Allergy 2009; 64: 1407-1415. Go to original source... Go to PubMed...
  6. Désiréée Larenas-Linnemann. Sublingual immunotherapy in children: complete and updated review supporting evidence of effect. Curr Opin Allergy Clin Immunol 2009; 9: 168-176. Go to original source... Go to PubMed...
  7. Panzner P. Oralair - sublinguální tablety pro specifickou imunoterapii alergie způsobené pyly trav. Alergie 3/2010; 12: 214-219.
  8. Špičák V. Budoucnost specifické alergenové imunoterapie. Alergie 2010; 12: 275-276.
  9. Sedlák V. Nové klinické zkušenosti s léčbou těžkého astmatu anti-IgE protilátkou (omalizumabem). Farmakoterapie 2009; 5: 59-64.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.